Retinal Neovascularization Clinical Trial
The intra-vitreous injection (IVT) of anti-VEGF (vascular endothelial growth factor) is currently the standard treatment for retinal neovascularization. The VEGF stimulates endothelial cells' proliferation and migration. It also increases microvascular permeability. If the VEGFs have proven their efficiency in the decrease of choroidal neovascular proliferation, their impact of the head of the optic nerve's microvasculature is yet unknown. Knowing that this microvasculature provides the retinal nerve fibers with oxygen, located in the area of the head of the optic nerve, a vasoconstriction induced by the anti-VEGF may have an incidence on the loss of retinal nerve fibers.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650047 -
Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD
|
||
Recruiting |
NCT05130385 -
High Resolution Optical Coherence Tomography
|
||
Recruiting |
NCT03211741 -
Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema
|
Phase 4 | |
Recruiting |
NCT02486484 -
Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
|
Phase 2 | |
Terminated |
NCT02088151 -
Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina
|
N/A | |
Completed |
NCT00564148 -
Intravitreal Avastin in Proliferative Retinopathies
|
Phase 2 | |
Completed |
NCT01024998 -
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
|
Phase 1 | |
Completed |
NCT01769183 -
Squalamine for the Treatment in Proliferative Diabetic Retinopathy
|
Phase 2 | |
Completed |
NCT01102946 -
Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy
|
Phase 2 | |
Completed |
NCT04650672 -
Daily Testing at Home by NV-AMD Subjects With Notal Home OCT.
|
||
Completed |
NCT01494805 -
Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration
|
Phase 1/Phase 2 | |
Completed |
NCT00000153 -
Krypton-Argon Regression of Neovascularization Study (KARNS)
|
Phase 3 |